Is PLRX or PPCB more undervalued in 2026?

CirclFi compares Pliant Therapeutics, Inc. (PLRX) and Propanc Biopharma, Inc. (PPCB) using 13 institutional-grade valuation models. PLRX has a Quality of Company score of 4.3/10 while PPCB scores 3.7/10.

Which is a better buy — PLRX or PPCB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PLRX and PPCB valuations compare?

PLRX at $1.26 and PPCB at $1.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PLRX vs PPCB Valuation Comparison 2026 — Intrinsic Value Analysis

PLRX

Pharmaceutical Preparations

Pliant Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$1.26

Last close

Models

7/13

Active

PPCB

Pharmaceutical Preparations

Propanc Biopharma, Inc.

Quality

3.7

out of 10

Value Trap

LOW

Price

$1.82

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	PLRX Fair Value	PLRX Upside	PPCB Fair Value	PPCB Upside
Bayesian DCF	Intrinsic	$0.10	-91.8%	$0.51	-72.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.22	+155.6%	$6.64	+264.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PLRX vs PPCB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PLRX vs PPCB — Which Stock Is More Undervalued?

PLRX scores higher with a 4.3/10 quality rating vs PPCB's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Pliant Therapeutics, Inc. (PLRX) and Propanc Biopharma, Inc. (PPCB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PLRX currently trades at $1.26 with a QOC of 4.3/10, while PPCB trades at $1.82 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).